Spots Global Cancer Trial Database for lobular breast carcinoma in situ
Every month we try and update this database with for lobular breast carcinoma in situ cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer | NCT01706432 | Central Nervous... Invasive Ductal... Invasive Ductal... Invasive Lobula... Invasive Lobula... Liver Metastase... Lobular Breast ... Lung Metastases Male Breast Can... Medullary Ducta... Mucinous Ductal... Papillary Ducta... Recurrent Breas... Stage IV Breast... Tubular Ductal ... Tumors Metastat... | hyperfractionat... laboratory biom... stereotactic ra... | 18 Years - | University of Chicago | |
| S9630, Medroxyprogesterone in Treating Women With Breast Cancer | NCT00002920 | Breast Cancer Endometrial Can... | medroxyprogeste... tamoxifen citra... adjuvant therap... | 18 Years - | SWOG Cancer Research Network | |
| Group-Based Lifestyle Intervention in Measuring Biomarker Levels in Participants at High Risk for Breast Cancer | NCT01874184 | Atypical Ductal... Atypical Lobula... BRCA1 Mutation ... BRCA2 Mutation ... Ductal Breast C... Lobular Breast ... | counseling inte... behavioral diet... exercise interv... questionnaire a... laboratory biom... | 35 Years - 65 Years | University of Washington | |
| Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer | NCT01869764 | Ductal Breast C... Lobular Breast ... Male Breast Can... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | omega-3 fatty a... placebo laboratory biom... | 18 Years - | Wake Forest University Health Sciences | |
| Study of Barriers to Beginning and Finishing Treatment for Patients With Breast Cancer | NCT00937989 | Breast Cancer | educational int... informational i... medical chart r... questionnaire a... study of socioe... quality-of-life... | 50 Years - | City of Hope Medical Center | |
| Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation Therapy | NCT01819233 | Ductal Breast C... Invasive Ductal... Invasive Lobula... Lobular Breast ... Recurrent Breas... Stage IA Breast... Stage IB Breast... | Behavioral diet... Therapeutic con... Radiation thera... Counseling inte... Quality-of-life... | 18 Years - | Thomas Jefferson University | |
| Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer | NCT01556243 | Breast Cancer | therapeutic con... whole breast ir... | 40 Years - | Alliance for Clinical Trials in Oncology | |
| Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery | NCT01082211 | Breast Cancer | 3D-Conformal Ex... | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
| Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer | NCT01077453 | Healthy, no Evi... Lobular Breast ... | letrozole quality-of-life... laboratory biom... | 35 Years - | National Cancer Institute (NCI) | |
| Genetics of Women With Lobular Carcinoma in Situ of the Breast | NCT00536718 | Breast Cancer | gene expression... molecular diagn... polymorphism an... protein express... medical chart r... questionnaire a... | - 60 Years | National Cancer Institute (NCI) | |
| Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease | NCT00898508 | Breast Cancer | gene expression... mutation analys... proteomic profi... reverse transcr... fluorescent ant... immunohistochem... laboratory biom... liquid chromato... mass spectromet... medical chart r... quality-of-life... | 20 Years - | City of Hope Medical Center | |
| Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer | NCT01556243 | Breast Cancer | therapeutic con... whole breast ir... | 40 Years - | Alliance for Clinical Trials in Oncology | |
| Comparison of Biomarkers Based on Fine-Needle Aspiration in Women at Increased or Normal Risk of Breast Cancer | NCT00041353 | Breast Cancer | cytology specim... comparison of s... study of high r... | 30 Years - | Fox Chase Cancer Center | |
| Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer | NCT01905046 | Atypical Ductal... BRCA1 Mutation ... BRCA2 Mutation ... Ductal Breast C... Lobular Breast ... | metformin hydro... placebo | 25 Years - 55 Years | Alliance for Clinical Trials in Oncology | |
| Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer | NCT01869764 | Ductal Breast C... Lobular Breast ... Male Breast Can... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | omega-3 fatty a... placebo laboratory biom... | 18 Years - | Wake Forest University Health Sciences | |
| Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease | NCT00031720 | Breast Cancer Hot Flashes Hot Flushes | soy protein isoflavones Tamoxifen Placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation Therapy | NCT01819233 | Ductal Breast C... Invasive Ductal... Invasive Lobula... Lobular Breast ... Recurrent Breas... Stage IA Breast... Stage IB Breast... | Behavioral diet... Therapeutic con... Radiation thera... Counseling inte... Quality-of-life... | 18 Years - | Thomas Jefferson University | |
| Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease | NCT00898508 | Breast Cancer | gene expression... mutation analys... proteomic profi... reverse transcr... fluorescent ant... immunohistochem... laboratory biom... liquid chromato... mass spectromet... medical chart r... quality-of-life... | 20 Years - | City of Hope Medical Center | |
| A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer | NCT00637481 | Atypical Ductal... Breast Cancer Ductal Breast C... Lobular Breast ... | atorvastatin ca... laboratory biom... | 18 Years - 72 Years | National Cancer Institute (NCI) | |
| A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer | NCT00637481 | Atypical Ductal... Breast Cancer Ductal Breast C... Lobular Breast ... | atorvastatin ca... laboratory biom... | 18 Years - 72 Years | National Cancer Institute (NCI) | |
| Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease | NCT00898508 | Breast Cancer | gene expression... mutation analys... proteomic profi... reverse transcr... fluorescent ant... immunohistochem... laboratory biom... liquid chromato... mass spectromet... medical chart r... quality-of-life... | 20 Years - | City of Hope Medical Center | |
| Educational Counseling in Improving Communication and Quality of Life in Spouses and Breast Cancer Patients | NCT01723943 | Anxiety Disorde... Depression Ductal Breast C... Lobular Breast ... Psychosocial Ef... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | educational int... counseling inte... educational int... psychosocial su... | - | University of Washington | |
| Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer | NCT01219075 | BRCA1 Mutation ... BRCA2 Mutation ... Ductal Breast C... Lobular Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... | soy isoflavones placebo questionnaire a... magnetic resona... biopsy immunohistochem... laboratory biom... mammography | 30 Years - 75 Years | University of Southern California | |
| Ductal Lavage in Assessing Women With Early Breast Cancer or at High Risk of Developing Breast Cancer and Who Are Eligible For Tamoxifen Therapy | NCT00083044 | Breast Cancer | 18 Years - 64 Years | Northwestern University | ||
| Flaxseed in Preventing Breast Cancer in Premenopausal Women at Risk of Developing Breast Cancer | NCT00794989 | Breast Cancer Precancerous Co... | Ground Flaxseed No Intervention | 21 Years - 50 Years | Roswell Park Cancer Institute | |
| Educational Counseling in Improving Communication and Quality of Life in Spouses and Breast Cancer Patients | NCT01723943 | Anxiety Disorde... Depression Ductal Breast C... Lobular Breast ... Psychosocial Ef... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | educational int... counseling inte... educational int... psychosocial su... | - | University of Washington | |
| Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer | NCT00096369 | Breast Cancer | tamoxifen citra... | 35 Years - 120 Years | University of Texas Southwestern Medical Center | |
| S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer | NCT01097278 | brca1 Mutation ... brca2 Mutation ... Breast Cancer | cholecalciferol placebo | 18 Years - 50 Years | SWOG Cancer Research Network | |
| Flaxseed in Preventing Breast Cancer in Premenopausal Women at Risk of Developing Breast Cancer | NCT00794989 | Breast Cancer Precancerous Co... | Ground Flaxseed No Intervention | 21 Years - 50 Years | Roswell Park Cancer Institute | |
| Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer | NCT01869764 | Ductal Breast C... Lobular Breast ... Male Breast Can... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | omega-3 fatty a... placebo laboratory biom... | 18 Years - | Wake Forest University Health Sciences | |
| Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer | NCT00004205 | Breast Cancer | letrozole tamoxifen citra... | 30 Years - 120 Years | ETOP IBCSG Partners Foundation | |
| Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer | NCT00096369 | Breast Cancer | tamoxifen citra... | 35 Years - 120 Years | University of Texas Southwestern Medical Center | |
| Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer | NCT01905046 | Atypical Ductal... BRCA1 Mutation ... BRCA2 Mutation ... Ductal Breast C... Lobular Breast ... | metformin hydro... placebo | 25 Years - 55 Years | Alliance for Clinical Trials in Oncology | |
| Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors | NCT01849250 | Benign Breast N... Ductal Breast C... Invasive Breast... Lobular Breast ... Paget Disease o... Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | Docosahexaenoic... Placebo | 18 Years - | National Cancer Institute (NCI) | |
| Study of Barriers to Beginning and Finishing Treatment for Patients With Breast Cancer | NCT00937989 | Breast Cancer | educational int... informational i... medical chart r... questionnaire a... study of socioe... quality-of-life... | 50 Years - | City of Hope Medical Center | |
| Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer | NCT01905046 | Atypical Ductal... BRCA1 Mutation ... BRCA2 Mutation ... Ductal Breast C... Lobular Breast ... | metformin hydro... placebo | 25 Years - 55 Years | Alliance for Clinical Trials in Oncology | |
| Ductal Lavage in Assessing Women With Early Breast Cancer or at High Risk of Developing Breast Cancer and Who Are Eligible For Tamoxifen Therapy | NCT00083044 | Breast Cancer | 18 Years - 64 Years | Northwestern University | ||
| Breast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer | NCT00666731 | Breast Cancer Precancerous Co... | medical chart r... questionnaire a... study of socioe... Excess human bi... quality-of-life... | 19 Years - 120 Years | University of Nebraska | |
| A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer | NCT00637481 | Atypical Ductal... Breast Cancer Ductal Breast C... Lobular Breast ... | atorvastatin ca... laboratory biom... | 18 Years - 72 Years | National Cancer Institute (NCI) | |
| Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer | NCT00004205 | Breast Cancer | letrozole tamoxifen citra... | 30 Years - 120 Years | ETOP IBCSG Partners Foundation | |
| Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy | NCT02314156 | BRCA1 Mutation ... BRCA2 Mutation ... Ductal Breast C... Lobular Breast ... Stage 0 Breast ... Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... | Telapristone Ac... Placebo Telapristone Ac... Placebo Laboratory Biom... Questionnaire A... | 18 Years - | Northwestern University | |
| Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer | NCT00096369 | Breast Cancer | tamoxifen citra... | 35 Years - 120 Years | University of Texas Southwestern Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
